the Leaders
in Medtech
Trusted By The Companies Pioneering What’s Next
Industry-leading executives from emerging companies,
venture capital and private equity firms, family offices,
investment banks, global strategics, and more.
-
.png)
.png)
.png)
Josh Makower
Director & Co-Founder, Stanford Byers Center for Biodesign
Venture Partner, Sofinnova Partners
.png)
.png)
.png)
-
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
-
Brett Wall
EVP and President, Neurosciences Portfolio, Executive Sponsor African Descent Network
Medtronic
.png)
.png)
.png)
.png)
.png)
Josh Makower
Director & Co-Founder, Stanford Byers Center for Biodesign
Venture Partner, Sofinnova Partners
Present to a full house of investors and strategics
alongside the CEOs and Founders building
technology that is shaping the future of healthcare.
-
Why not use technology to reduce the risk of chronic use and addiction when prescribing addictive medications, while also saving valuable time for healthcare professionals? Prescriby is a data-driven treatment management platform designed for addictive medications. It provides a safe and efficient solution for health clinics managing and prescribing substances like opioids and benzodiazepines. Visit website.
-small.jpg)
Kjartan Thorsson
CEO
-
Pulsli have created an AI-enabled fluid overload predictor in patients with congestive heart failure. The clinically validated technology provides noninvasive remote patient self-monitoring, improving user engagement and reducing the workload of health professionals. Visit website.
Sasha Banjac
CEO & Founder
-
Imaginostics is developing next-generation diagnostic solutions to support clinicians and drug developers. The company’s QUTE-CE MRI technology is a noninvasive quantitative imaging solution that enhances existing MRI machines with quantitative measuring capabilities to measure vascular function and structure. Imaginostics is actively utilizing its technology in pre-clinical and clinical research in the fields of cardiology, oncology and neuroscience. Visit website.
-small.jpg)
Codi Gharagouzloo
CSO
-
GenesisTissue is developing regenerative breast tissue using advanced 3D bioprinting technology. The technology combines a bioprinted personalized breast scaffold with the patient’s own fat cells to create an engineered tissue solution that regenerates. By combining presurgical planning, plan-specific guidance, and personalized implant design, GenesisTissue aims to advance breakthroughs in tissue engineering for reconstructive and cosmetic breast indications, with potential for broader soft tissue applications.
-small.jpg)
Katie Weimer
CEO & Co-founder
-
---2025-05-08T140150.767-small.png)
BRIJ Medical develops advanced solutions for incision closure, wound support, and scar therapy. The company’s flagship product, the Brijjit® Force Modulating Tissue Bridge, has been clinically proven to reduce wound breakdown and scar formation by minimizing tension on healing tissues. Designed for efficiency, it enables faster closure compared to traditional sutures and offers a cost-effective option for surgeons, ambulatory surgery centers, and hospitals. Visit website.
-small.jpg)
Tim Gleeson
CEO and Board Member
-
Calla Lily Clinical Care is a women's health focused company which has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in IVF and miscarriage prevention, followed by delivery of live biotherapeutics (LBPs) to reduce antibiotic usage which contributes to antimicrobial resistance (AMR). Further use-cases include effective sample collection to facilitate the next generation of biomarker-based diagnostic tests for endometriosis and a wide range of other conditions. Visit website.
Lara Zibners
Co-Founder & Chairman
-
DeepSight™ has developed a breakthrough sensor + imaging platform that powers low-cost, smart instruments for image-guided procedures. Many of today’s interventions rely on CT or fluoroscopy and highly skilled specialists—resources in limited supply worldwide. By embedding advanced sensors directly into needle- and catheter-based tools, DeepSight delivers AI-assisted, ultrasound-based tracking, real-time guidance, pressure and temperature sensing, and an industry first: an ultrasound view from the tip of the instrument anywhere in the body Visit website.
Alyssa Abo, MD MBA
Vice President of Clinical Innovation
-
Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.
David Constantine
CEO
-
Cultivating brain health therapy through continuous, ultra-long-term EEG monitoring and transformative real-world data. Our MDR CE-approved 24/7 EEG SubQ solution captures subcutaneous brain activity to deliver actionable insights that empower clinicians and researchers to personalize treatment and reduce uncontrolled seizures in epilepsy. By harnessing AI and big data, we are unlocking new possibilities in digital biomarkers, drug development, and neuromodulation. Visit website.
Martin Stenfeldt
CEO
-
AiM Medical Robotics is a Massachusetts-based neurosurgical robotics company commercializing a compact, MRI-compatible surgical robot that enables intra-operative imaging to account for brain shift and facilitate real-time monitoring of therapy delivery. AiM’s platform harnesses real-time MRI to ensure precise placement of neurostimulation leads for Parkinson’s patients and its versatile capabilities also support a wide range of neurosurgical procedures, including biopsies, tumor ablation, and intracranial therapeutic delivery with a >$10B market opportunity. Built on over 15 years of NIH-funded research totaling approximately $15 million, AiM’s proprietary and patented technology reflects the deep expertise of its founding team that completed an $8.1 million Series A financing round funding a first-in-human clinical trial at Brigham and Women’s Hospital in Boston. Visit website.
Gregory Fischer, PhD
Founder & CEO
-
---2025-05-08T140904.221-small.png)
Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation. Visit website.
-small.jpg)
Dimitri Sokolov
CEO
-
---2025-05-08T141154.783-small.png)
Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website.
Patryk Kania
CEO and President
-
ReNavie Sensing is the new novel technology focusing on mapping Renal Denervation and solving non responder issue. Visit website.
Marcin Golebicki
CEO and Founder
-
Hemanext commercializes Hemanext ONE, an FDA-authorized and CE-marked system that processes and stores red blood cells under low-oxygen conditions to produce a standardized hypoxic RBC component. The system operates within established blood-establishment and hospital workflows and is supported by a dedicated CMS reimbursement code above the standard rate for conventional RBCs. Hemanext ONE enables the production and use of hypoxic red blood cells for patients who depend on transfusion therapy.Visit website.
Daan Kok
Head of BD and Strategy
-
AutoMedicus Corporation has developed a transformative closed-loop blood pressure control device, called the AutoPress, for use in the OR and ICU. The AutoPress was recently designated as a Breakthrough device by the FDA (CDRH). Visit website.
-small.jpg)
William "Bill" Harrity, M.D.
Chief Medical Officer and Co-Founder
-
Solaris Endovascular, Inc. is a growth stage, US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health. Visit website.
Randy Hubbell
President & CEO
-
Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at theradial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home. Visit website.
Ray Liu
CEO & Co-Founder
-
Vergent’s lead compound, abenacianine for injection (VGT-309), is a next generation tumor-targeted fluorescent imaging agent for cancer surgery designed to provide real-time, intraoperative visual and molecular feedback on tumor location and help surgeons ensure all tumor tissue is removed during minimally invasive surgery (MIS) procedures. Abenacianine is designed to be an ideal targeted imaging agent and is compatible across NIR enabled surgical visualization platforms, works across all solid tumor types, and has a differentiated mechanism of action that allows for a wide dosing window to seamlessly fit into surgery workflows. Visit website.
John Santini
President & CEO
-
The TriPair™ Technology is a novel minimally invasive tricuspid repair solution designed to treat Tricuspid Regurgitation —a condition that affects millions globally, with the vast majority currently remaining untreated. TriPair™ simplifies transcatheter repair through an innovative edge-to-spacer approach, aiming to reduce procedural complexity and improve access to care. TriPair™ is designed to be simple, fast (procedure time under 30 minutes), and highly effective, empowering physicians in both established and underserved markets to treat patients who cannot be helped with existing technologies. Following a successful first-in-human trial, TriPair™ is now being prepared for evaluation in global feasibility studies across multiple continents. Visit website.
Jochen Reinöhl
CEO
-
The Somavac system is designed to apply deep tissue Negative Pressure Therapy to reduce and prevent the occurrence of seroma in patients who have recently undergone breast reconstruction and mastectomies. Somavac is intended to reduce post-operative complications and the time requiring surgical drains following surgery. The system is self-contained within a belt to discretely remove fluid and prevent build-up that can lead to complications. Visit website.
Elizabeth Hoff
Board Member
-
.svg)
Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. Visit website.
-small.jpg)
Leo Smit
CEO
-
---2025-05-08T142020.025-small.png)
Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures. Visit website.
Justin Anderson
CEO
-
Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.
Vijit Sabnis
Co-Founder
-
---2025-05-08T140023.211-small.png)
InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.
Peter Fischer
CEO
-
-small.jpg)
Arsenal Medical develops innovative biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and bleeding conditions, such as hemorrhage. Visit website.
Upma Sharma
President & CEO
-
SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. Visit website.
Olivier Delporte
CEO
-
Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software. Visit website.
Peter Vranes
CEO
-
Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence. Visit website.
Samantha Pulliam
CEO
-
iO Urology aims to improve the lives of people living with urologic conditions. The company’s CarePath device is a remote patient monitoring system to promote urologic care at home. CarePath provides real-time, quantitative measurement of urinary output and flow to support the management of lower urinary tract symptoms from conditions such and benign prostatic hypertrophy and overactive bladder. Visit website.
Britton Garrett
CEO
-
Prevencio develops personalized blood tests designed to improve the early detection and prevention of cardiovascular disease. Using machine learning, multi-proteomic biomarkers, and proprietary algorithms, Prevencio’s technology aims to provide more accurate diagnostic and prognostic insights than traditional methods. The company's patented tests have been published in leading cardiology journals and presented at major cardiovascular conferences. Prevencio’s approach is intended to reduce unnecessary procedures and improve patient outcomes. Visit website.
Rhonda Rhyne
CEO
-
Fundamental XR offers an Immersive VR platform for specialty suite procedures and is a strategic partner helping med-device leaders to solve the Competency at Scale Gap. Through its purpose-built immersive VR platform, FundamentalVR provides high-fidelity VR, including unique HapticVR capabilities, for the precision of specialty surgeries, as well as behavioral telemetry and assessment data for AI/ML-driven insights. Visit website.
Richard Vincent
CEO
-
Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration. Visit website.
Sujit Dike
CEO
-
---2025-05-08T141622.803-small.png)
Autonomix (Nasdaq: AMIX) is a medical device company developing a minimally invasive nerve-sensing, ablation, and verification system to advance the diagnosis and treatment of diseases involving the nervous system. The company’s catheter-based microchip sensing array is designed to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than existing technologies. This platform enables transvascular diagnosis and treatment of conditions affecting the peripheral nervous system. Initially focused on pancreatic cancer pain, Autonomix’s technology has potential applications across multiple fields, including cardiology, renal denervation, and chronic pain management. Visit website.
Brad Hauser
CEO
-
Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.
Jennifer Fried
CEO
-
---2025-05-08T141416.780-small.png)
THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.
Stuart Simpson
CEO
-
URO-1is an emerging medtech company developing proprietary surgical solutions for office-based urology. The company is targeting the challenges associated with inadequate biopsy, which can lead to increased costs, procedure duplication, and diagnostic delay. The SUREcore and coreCARE platforms are two solutions within the company’s portfolio that are intended to improve the standard of care in prostate biopsy and other soft tissue biopsy procedures. Visit website.
Ted Belleza
CEO
-
Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visit website.
Rob Krummen
CEO
-
-small.jpg)
The current course of treatments for lower back pain ends in failure. Spinal fusion, the final treatment option, has amassed a well documented record of problems: biomechanical distortions, ASD, and reoperations. Aposture Surgical has reimagined and redesigned the fixation system to have durability and natural flexibility. The result is better fusion, preservation of natural mobility for the patient, and an unprecedented reduction of reoperations due to ASD. ApostureFlex can transform outcomes for spinal surgery. Visit website.
John H. Chung
Co-Founder & CEO
-
---2025-05-08T141058.024-small.png)
Anaut is a Tokyo-based technology company that is passionate about using the power of AI to drive innovation in the healthcare industry. Our mission is to revolutionize surgery by developing AI precision mapping technology that can improve surgical outcomes and reduce the risk of complications. Our flagship product, Surgical Vision EUREKA, is a game-changing solution that has been specifically designed to support this mission. EUREKA uses cutting-edge algorithms and deep learning methodologies to achieve real-time precision mapping of the surgical field, allowing surgeons to navigate through complex anatomical structures with greater precision and accuracy. By leveraging the power of AI, we believe that we can transform the surgical landscape and provide better outcomes for patients around the world. Visit website.
James Grosvenor
VP of Global Operations
-
CygnusMed is advancing endovascular care with a novel hemostatic valve designed to provide continuous, uninterrupted sealing of the guiding catheter during interventions. The device enables arterial blood pressure monitoring without the need for a second arterial line, minimizes blood loss, and supports continuous saline flushing of the catheter to significantly reduce the risk of iatrogenic emboli. By addressing critical challenges in endovascular procedures, CygnusMed's innovative solution enhances safety, efficiency, and patient outcomes. Visit website.
Firas Al-Ali M.D.
Founder and CEO
-
---2025-05-08T140620.646-small.png)
Rekovar develops wearable biosensor technology aimed at improving the management of Neonatal Abstinence Syndrome (NAS). Its flagship product, NeoMonki, is an investigational neonatal monitoring kit designed to provide real-time, objective data on infants' physiological and behavioral states. The system includes a wristband sensor, imaging camera, tablet application, and a provider portal, enabling healthcare professionals to deliver personalized care and intervention. Visit website.
Shiva Sharareh
CEO
-
Nitinotes develops the EndoZip™, the first fully automated endoscopic suturing system for Endoscopic Sleeve Gastroplasty (ESG), a minimally invasive weight-loss procedure. Designed for efficiency, EndoZip enables a single-operator ESG procedure with automated, standardized suturing, reducing variability, procedure time, and training requirements. The system facilitates outpatient treatment with low-risk and predictable outcomes, addressing the growing need for effective, non-surgical obesity interventions. Visit website.
Lloyd Diamond
CEO
-
---2025-05-08T140514.598-small.png)
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.
Bart Bandy
CEO
-
Osheru has developed innovative technology using compression skin contouring to remove excess unwanted skin. Our first product, the Ziplyft, makes an eyelid lift minimally invasive and easier on the surgeon and the patient, increasing efficiency by eliminating the need for cautery and suturing. With Ziplyft, surgeons can offer a premium experience to their patients and patients benefit with a natural refreshed look with improved symmetry, reduced downtime, and faster recovery than traditional blepharoplasty. At Osheru we are ‘Opening Eyes Beautifully'. Visit website.
Patricia Buehler
CEO & Founder
-
CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website.
Ilan Uchitel
CEO & Co-Founder
-
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. The company's innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. Visit website.
John Wong
Co-Founder and CEO
-
4C Medical's AltaValve is a supra-annular transcatheter mitral valve replacement (TMVR) system. The AltaValve system is intended to streamline the procedure to replace degenerated mitral valves compared to current solutions. AltaValve will also expand the population of patients eligible for treatment to include those who have undergone previous valve repair operations. Visit website.
Saravana Kumar
President & CEO
-
Sovato is creating access to high-quality care by enabling and orchestrating safe, scalable, and profitable remote robotic surgery and procedure programs that span the entire surgical journey. Sovato is the world’s first and only robot-agnostic platform enabling remote programs for healthcare organizations at a global scale. Visit website.
Cynthia Perazzo
Co-Founder and CEO
Book Hotel with Discounted
LSI
Rates Before They're Gone
Monarch Beach Resort & Club. These exclusive LSI rates are limited and sell
out early each year. We strongly recommend booking your room as soon as
possible to ensure availability.
Sponsorship opportunities
Elevate your brand and
accelerate growth at the
epicenter of the industry
Don't take our word for it.
Explore real success stories
sessions from previous events, captivating photos, and the latest
alumni news. Dive in today to prepare for your next LSI experience.
© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
